We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$122M
AUM Growth
-$1.06M
Cap. Flow
+$5.5M
Cap. Flow %
4.49%
Top 10 Hldgs %
73.33%
Holding
57
New
2
Increased
26
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
XERS icon
Xeris Biopharma Holdings
XERS
+$13.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$4.5M
3
RZLT icon
Rezolute
RZLT
+$4.49M
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$3.03M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.61M

Top Sells

Rank Stock Value
1
SBBP
Strongbridge Biopharma plc.
SBBP
+$16.4M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.96M
3
KALA icon
KALA BIO
KALA
+$3.19M
4
GIGGU
GigCapital4, Inc. Unit
GIGGU
+$459K
5
SWBK.U
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
+$398K

Sector Composition

Rank Sector Weight
1 Healthcare 66.24%
2 Financials 10.38%
3 Communication Services 4.24%
4 Technology 3.26%
5 Consumer Discretionary 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XERS icon
1
Xeris Biopharma Holdings
XERS
$1.52B
$18.5M 15.11%
+6,310,546
New +$13.6M
CRDF icon
2
Cardiff Oncology
CRDF
$60.2M
$15.2M 12.39%
2,522,083
– –
SCYX icon
3
SCYNEXIS
SCYX
$42.4M
$10.7M 8.72%
218,598
+23,048
+12% +$1.13M
SVRA icon
4
Savara
SVRA
$1.13B
$8.58M 7.01%
6,916,551
+20,000
+0.3% +$23.8K
MTEM
5
DELISTED
Molecular Templates, Inc.
MTEM
$8.38M 6.85%
142,533
– –
GLD icon
6
SPDR Gold Trust
GLD
$130B
$6.98M 5.7%
40,820
– –
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$5.72M 4.67%
262,969
-179,785
-41% -$3.96M
RZLT icon
8
Rezolute
RZLT
$444M
$5.71M 4.66%
1,193,473
+769,230
+181% +$4.49M
CTIC
9
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5.55M 4.54%
2,239,300
+1,239,300
+124% +$3.03M
PSTH
10
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$4.48M 3.66%
+227,000
New +$4.5M
SPY icon
11
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$3.31M 2.71%
6,980
+3,500
+101% +$1.61M
LUXA
12
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$1.96M 1.6%
200,000
– –
ADXN
13
Addex Therapeutics
ADXN
$7.22M
$1.67M 1.37%
13,297
– –
EFA icon
14
iShares MSCI EAFE ETF
EFA
$76.5B
$1.5M 1.22%
19,000
– –
AAC.U
15
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$1.39M 1.13%
139,680
– –
INTU icon
16
Intuit
INTU
$79.6B
$1.28M 1.05%
1,989
+105
+6% +$64.8K
GOOG icon
17
Alphabet (Google) Class C
GOOG
$4.22T
$1.16M 0.94%
7,980
+540
+7% +$78K
MSFT icon
18
Microsoft
MSFT
$2.93T
$1.11M 0.91%
3,299
+242
+8% +$78.5K
SPGI icon
19
S&P Global
SPGI
$133B
$1.06M 0.87%
2,251
+179
+9% +$81.9K
MCO icon
20
Moody's
MCO
$89.2B
$1.01M 0.83%
2,600
+220
+9% +$84.9K
META icon
21
Meta Platforms (Facebook)
META
$1.64T
$955K 0.78%
2,840
+275
+11% +$91.3K
AMT icon
22
American Tower
AMT
$79.2B
$948K 0.77%
3,240
+346
+12% +$94.5K
WHR icon
23
Whirlpool
WHR
$2.48B
$917K 0.75%
3,906
+418
+12% +$91.8K
NFLX icon
24
Netflix
NFLX
$290B
$912K 0.75%
15,130
+1,560
+11% +$99.7K
MDLZ icon
25
Mondelez International
MDLZ
$78.3B
$901K 0.74%
13,582
+1,544
+13% +$95.3K
1
2 3

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q4 2021 Portfolio in Review

As of Q4 2021, Caxton Corporation held 57 positions worth $122M, down 0.86% from $123M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Caxton Corporation deployed $5.5M of net new capital in Q4 2021, opening 2 new positions and adding to 26 existing holdings. Its largest new stake was Xeris Biopharma Holdings: 6,310,546 shares worth $18.5M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 73% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Sierra Oncology, Inc. Common Stock, an estimated $3.96M trimmed.

  • Caxton Corporation's largest Q4 2021 buy was Xeris Biopharma Holdings: 6,310,546 shares worth $18.5M.
  • Caxton Corporation added most to Rezolute in Q4 2021, an estimated $4.49M increase.
  • Caxton Corporation's biggest Q4 2021 reduction was Sierra Oncology, Inc. Common Stock, cutting an estimated $3.96M.
  • Caxton Corporation fully exited Strongbridge Biopharma plc. in Q4 2021, selling an estimated $16.4M.
  • Caxton Corporation's ten largest holdings make up 73% of its $122M portfolio in Q4 2021.
  • Caxton Corporation opened 2 new positions and closed 5 in Q4 2021.
  • Caxton Corporation's portfolio value fell 0.86% quarter-over-quarter to $122M.

Based on Caxton Corporation's 13F filing for Q4 2021, filed 14 Feb 2022.